You have 9 free searches left this month | to do more
Showing 1 - 25 of
5,342 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Duarte, California
  • +1 more
2022-03-17
Mar 17, 2022
I
Recruiting
  • Solid Tumors
  • +2 more
  • Cyclophosphamide and JX-594 dose escalation
  • +3 more
  • Bordeaux, France
    Institut Bergonie
2022-02-01
Feb 1, 2022
K
Recruiting
  • Cardio-oncology
  • +4 more
    • Jinan, Shandong, China
      Qianfoshan Hospital (The First Affiliated Hospital of Shandong F
    2021-11-27
    Nov 27, 2021
    H
    Recruiting
    • Hematological Malignancy
    • Detroit, Michigan
      Henry Ford hospital
    2021-12-23
    Dec 23, 2021
    S
    Withdrawn
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Cyclophosphamide
    • (no location specified)
    2021-11-02
    Nov 2, 2021
    M
    Completed
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2022-03-03
    Mar 3, 2022
    U
    Recruiting
    • Metastatic Thyroid Cancer
    • Ann Arbor, Michigan
      University of Michigan Cancer Center
    2021-12-15
    Dec 15, 2021
    S
    Not yet recruiting
    • Hematopoietic Stem Cell Transplantation
    • Drug: Cyclophosphamide
    • (no location specified)
    2021-06-22
    Jun 22, 2021
    C
    Completed
    • Neuroendocrine Tumors
    • Besancon, France
    • +1 more
    2021-07-30
    Jul 30, 2021
    H
    Terminated
    • Graft Versus Host Disease
    • Cyclophosphamide and Sirolimus
    • +3 more
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    2022-02-04
    Feb 4, 2022
    A
    Suspended
    • Leukemia, Not Otherwise Specified
    • Leukemia, Other
    • Cyclophosphamide
    • Specimen collection
    • Charlotte, North Carolina
      Levine Cancer Institute
    2022-02-15
    Feb 15, 2022
    C
    Recruiting
    • Lipodystrophy Acquired
    • Type1diabetes
    • Cyclophosphamide
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    2021-10-21
    Oct 21, 2021
    E
    Active, not recruiting
    • Multiple Myeloma
    • Torino, Italy
      Fondazione EMN Italy Onlus
    2022-03-24
    Mar 24, 2022
    E
    Active, not recruiting
    • Multiple Myeloma
    • Torino, Italy
      Fondazione EMN Italy Onlus
    2022-03-24
    Mar 24, 2022
    S
    Completed
    • HIV
    • SB-728-T
    • Los Angeles, California
    • +10 more
    2021-04-26
    Apr 26, 2021
    I
    Active, not recruiting
    • Soft-tissue Sarcomas
    • Phase 1: Trabectedin
    • +3 more
    • Bordeaux, France
      Institut Bergonié
    2021-05-04
    May 4, 2021
    T
    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Cyclophosphamide 50mg
    • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
    • Cambridge, United Kingdom
    • +3 more
    2022-02-01
    Feb 1, 2022
    N
    Active, not recruiting
    • Adult T-Cell Leukemia (ATL)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-01-13
    Jan 13, 2022
    D
    Recruiting
    • GVHD
    • Hematologic Neoplasms
    • Cyclophosphamide
    • +3 more
    • La Jolla, California
      UC San Diego Moores Cancer Center
    2022-03-21
    Mar 21, 2022
    U
    Recruiting
    • Advanced Soft-tissue Sarcoma
    • Metastatic Soft-tissue Sarcoma
    • Toulouse, France
      Institut Claudius Reagaud-IUCT Oncopôle
    2021-09-27
    Sep 27, 2021
    H
    Completed
    • Chronic Fatigue Syndrome (CFS)
    • Myalgic Encephalomyelitis (ME)
    • Cyclophosphamide
    • Bergen, Norway
      Dept. of Oncology, Haukeland University Hospital
    2021-05-10
    May 10, 2021